These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 2479704
21. Characterization of a tolerogenic T cell epitope of type II collagen and its relevance to collagen-induced arthritis. Myers LK, Terato K, Seyer JM, Stuart JM, Kang AH. J Immunol; 1992 Aug 15; 149(4):1439-43. PubMed ID: 1380044 [Abstract] [Full Text] [Related]
22. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis. Myers LK, Tang B, Rosloniec EF, Stuart JM, Chiang TM, Kang AH. J Immunol; 1998 Oct 01; 161(7):3589-95. PubMed ID: 9759881 [Abstract] [Full Text] [Related]
23. Bystander suppression of murine collagen-induced arthritis by long-term nasal administration of a self type II collagen peptide. Bayrak S, Mitchison NA. Clin Exp Immunol; 1998 Jul 01; 113(1):92-5. PubMed ID: 9697989 [Abstract] [Full Text] [Related]
30. T cell regulation of collagen-induced arthritis in mice. III. Is T cell vaccination a valuable therapy? Chiocchia G, Manoury-Schwartz B, Boissier MC, Gahery H, Marche PN, Fournier C. Eur J Immunol; 1994 Nov 01; 24(11):2775-83. PubMed ID: 7525304 [Abstract] [Full Text] [Related]
33. Epitope specificity and T cell receptor usage in type II collagen induced autoimmune ear disease. Yoo TJ, Lee MK, Min YS, Chiang HJ, Wang K, Fujiyoshi T, Watanabe T, Krug MS, Seyer J, Cheng KC. Cell Immunol; 1994 Aug 01; 157(1):249-62. PubMed ID: 7518752 [Abstract] [Full Text] [Related]
34. Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Malmström V, Michaëlsson E, Burkhardt H, Mattsson R, Vuorio E, Holmdahl R. Proc Natl Acad Sci U S A; 1996 Apr 30; 93(9):4480-5. PubMed ID: 8633094 [Abstract] [Full Text] [Related]
35. Intranasal administration of denatured type II collagen and its fragments can delay the onset of collagen-induced arthritis. Matsumoto T, Ametani A, Hachimura S, Iwaya A, Taguchi Y, Fujita K, Shigehisa T, Kaminogawa S. Clin Immunol Immunopathol; 1998 Jul 30; 88(1):70-9. PubMed ID: 9683552 [Abstract] [Full Text] [Related]
36. Chronicity of arthritis induced with homologous type II collagen (CII) in rats is associated with anti-CII B-cell activation. Holmdahl R, Vingsbo C, Malmström V, Jansson L, Holmdahl M. J Autoimmun; 1994 Dec 30; 7(6):739-52. PubMed ID: 7888032 [Abstract] [Full Text] [Related]
38. Tolerance induction by a poorly arthritogenic collagen II can prevent collagen-induced arthritis. van Vollenhoven RF, Nagler-Anderson C, Soriano A, Siskind GW, Thorbecke GJ. Cell Immunol; 1988 Aug 30; 115(1):146-55. PubMed ID: 3401929 [Abstract] [Full Text] [Related]
39. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice. Myers LK, Sakurai Y, Tang B, He X, Rosloniec EF, Stuart JM, Kang AH. Arthritis Rheum; 2002 Dec 30; 46(12):3369-77. PubMed ID: 12483744 [Abstract] [Full Text] [Related]
40. Identification of an immunodominant B-cell epitope in bovine type II collagen and the production of antibodies to type II collagen by immunization with a synthetic peptide representing this epitope. Morgan K, Turner SL, Reynolds I, Hajeer AH, Brass A, Worthington J. Immunology; 1992 Dec 30; 77(4):609-16. PubMed ID: 1283603 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]